Accelerated Phase Chronic Myelogenous Leukemia Completed Phase 2 Trials for Beclomethasone dipropionate (DB00394)

IndicationStatusPhase
DBCOND0028985 (Accelerated Phase Chronic Myelogenous Leukemia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00489203Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerSupportive Care